John Sourbeer
Stock Analyst at UBS
(3.87)
Main Sectors:
19 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
QGEN Qiagen | Maintains: Neutral | 48 50 | 46.8 | 6.84% | 5 | Aug 7, 2025 | |
WST West Pharmaceutical ... | Maintains: Strong Buy | 285 320 | 272.5 | 17.43% | 4 | Jul 25, 2025 | |
ICLR Icon | Maintains: Strong Buy | 170 240 | 193.89 | 23.78% | 2 | Jul 25, 2025 | |
CYRX CryoPort | Maintains: Strong Buy | 10 11 | 9.68 | 13.64% | 6 | Apr 1, 2025 | |
STVN Stevanato Group | Maintains: Neutral | 24 24 | 26 | -9.62% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 43 45 | 29.98 | 50.1% | 4 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 2 | 1.49 | 34.23% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 133 145 | 102.12 | 41.99% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 12 15 | n/a | n/a | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 452 480 | 532.49 | -9.86% | 4 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 8 | n/a | n/a | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 94 102 | 36.98 | 175.82% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 58 64 | n/a | n/a | 6 | Feb 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 7 3 | n/a | n/a | 2 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 50 | 12.75 | 292.16% | 1 | Feb 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 68 | n/a | n/a | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 142 128 | 134.58 | -4.89% | 2 | Jul 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 13 4 | n/a | n/a | 2 | Mar 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 23 | n/a | n/a | 1 | Feb 22, 2021 |